Article Text

PDF
Why do people with rheumatoid arthritis still die prematurely?
  1. S E Gabriel
  1. Professor S E Gabriel, Department of Health Sciences Research, Mayo Foundation, 200 First St SW, Rochester, MN 55905, USA; gabriel.sherine{at}mayo.edu

Abstract

Premature death has been long recognised as a manifestation of rheumatoid arthritis (RA). Three lines of evidence can explain why patients with RA die prematurely and why the mortality gap between patients with RA and the general population appears to widening. First, patients with RA have a higher risk of several serious comorbid conditions and they tend to experience worse outcomes after the occurrence of these illnesses. Second, patients with RA do not appear to receive optimal primary or secondary preventive care. And third, the systemic inflammation and immune dysfunction associated with RA appears to promote and accelerate comorbidity and mortality. This paper provides a brief summary and interpretation of the data underlying these findings. Together, these results provide a compelling argument in favour of a focused research programme aimed specifically at eliminating premature death in patients with RA.

Statistics from Altmetric.com

Footnotes

  • Funding: This work was supported by grants from the National Institutes of Health: R01 AR46849 and AR-30582.

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.